Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19
Y Yang, C Shen, J Li, J Yuan, J Wei, F Huang… - Journal of Allergy and …, 2020 - Elsevier
Background The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 was first reported in Wuhan, December 2019, and
continuously poses a serious threat to public health, highlighting the urgent need of
identifying biomarkers for disease severity and progression. Objective We sought to identify
biomarkers for disease severity and progression of COVID-19. Methods Forty-eight
cytokines in the plasma samples from 50 COVID-19 cases including 11 critically ill, 25 …
acute respiratory syndrome coronavirus 2 was first reported in Wuhan, December 2019, and
continuously poses a serious threat to public health, highlighting the urgent need of
identifying biomarkers for disease severity and progression. Objective We sought to identify
biomarkers for disease severity and progression of COVID-19. Methods Forty-eight
cytokines in the plasma samples from 50 COVID-19 cases including 11 critically ill, 25 …